NSEDisclosure under SEBI Takeover Regulations23 Jun 2026 · 23 Jun 2026, 04:15 pm
Disclosure under SEBI Takeover Regulations
Procter & Gamble Hygiene and Health Care Limited · PGHH
✦ AI Summary
Procter & Gamble Overseas India B.V., a promoter of Procter and Gamble Health Limited, has filed a disclosure under SEBI Takeover Regulations 31(4). The filing confirms its shareholding of 8,601,071 shares, amounting to 51.82% of Procter and Gamble Health Limited's paid-up capital. Furthermore, it declares that none of these shares were encumbered (pledged) as of March 31, 2026. This disclosure represents a routine compliance update.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Procter & Gamble Overseas India B.V. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Attachments (1)
📄pdf
Download →
team_sandeshc_28042026105731_PGHL.pdf
View document text
BusinUesses
Proc&Gt aemrb Olvee rIsnedaBis.a V .
Ween5a0,D5 e,l fPtosoTero tw,Be ,r
10tfhl o3o0r1,3R AoLt terdam
Netherlands
Apr2i2,l0 2 6
ThCeo rpoRrealtaDete ipoanrst ment LisDteipnagr tment
ThBeS LEi mited NatiSotnoEacxlkc hoaIfnn gdeLi iam ited
DeparotfCm oernpto Sreartvei ces ExchPalnagPzela No,otC . / CIB ,l ock,
PhirJoezeej eTeobwheorys , BandKruarC loam pBlaenx(d,Er aas t),
DalSatlr eet -M4u0m0b0a0i1 . Mumb-a4i0 0051
Ref:c-Socd5re0i 0p1 26 RefS:c-rCiopdP eG:H-L
DeaSri/M r adam,
SubDs:ic lousnudrReeersg ul3a1t(io4ofS)En B (ISb ustaAnctqiuailos fSih tairo&en Ts a ekovers)
Regula0t1i1o ns, 2
Purstuoat nhpter_ o viosfti hoRene gul3a1t(io4 ofS)nE B(IS ubstAacnqtuiioas fliS thiaor&ne s
TakeoRveegrusl)a2 t0i1wo1en,he s r,e dbeyc ltahrwaeetP , r cot &eG ramblOevr esaseIn d iBa.V.,
prmootreg ropuo fPr ocatne dGram blHeel atLhi mi(tteeatcdro gmpnaya)l ownigPt ehr sAocntisin n g
Conc(ePrAtCh se)r, eh boylatd to aofl8 6,0 1s,h0a7arm1eosu ntt io5n18g.2 %(detpariolvsii nd ed
annexbulerwoe)o fthteo tpaali ds-huacprai ept oa tflht ea rtcg oempany.
Wef rutehdre cltaahtrw,ee h avneom ta daen eyn cumbor ftahnaecb eeom vnetiosnheaddr ierse,c tly
ori ndirfeotcrhyt eel eaynr,d Meadr 3c1h2, 20 6.
Reuqeysot tu otk aete hs amoeny oruerc ords.
Thanykoiun,g
YourFsa ithful.ly,
FroP roe cr&tG ambOlvee rsIenaadB siV. .
AuthoSriigznyea dt
✓o L€Lr
C.tCo.:
ThAeu dCiotm mittee
Proc&Gt aemrb Hleea Llitmhi ted
P&PGl aza
CardGirnaacRlio aaCsdh ,a kala,
Andh(eEMr)ui,m b-4a0i0 099
Business Use
Procter & Gamble Overseas India B.V.
Weena, 505, Delftse Poort, Tower B,
10th floor, 3013AL Rotterdam
Netherlands
Annexure-1
Details of shareholding of promoters of Procter and Gamble Health Limited
Name of listed company Procter and Gamble Health limited
(target company)
Name of stock exchanges where BSE Limited
shares of the company are listed . National Stock Exchange of India Limited
Name of the promoter(s) / PACs Procter and Gamble Overseas 86·,01,071 shares
along with promoter shareholding India B.V. (�1.82% of paid-up share
in the listed company capital)
Encumbered shares as a % of NIL
promoter shareholding
For Procter & Gamble Overseas India B. V.
Authorized Signatory
Place: Rott erdam
April 2, 2026